DCM
XGN icon

Driehaus Capital Management’s Exagen XGN Stock Holding History

Driehaus Capital Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-480,918
Closed -$3.36M – 515
2025
Q2 		$3.36M Buy
480,918
+62,413
+15% +$379K 0.03% 317
2025
Q1 		$1.5M Hold
418,505
– – 0.01% 332
2024
Q4 		$1.72M Buy
+418,505
New +$1.51M 0.01% 315

Other funds holding XGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Driehaus Capital Management's XGN Position: Q3 2025 in Review

Driehaus Capital Management sold out of Exagen (XGN) in Q3 2025, closing a stake of 480,918 shares — an estimated $3.36M sold.

Driehaus Capital Management first reported a position in XGN in Q4 2024 and held it in 3 quarters. The position peaked at $3.36M in Q2 2025. 62 funds tracked by Wall St. Rank hold XGN as of Q3 2025.

  • Driehaus Capital Management reported no remaining Exagen position as of Q3 2025 after selling out during the quarter.
  • Driehaus Capital Management sold 480,918 Exagen shares in Q3 2025, an estimated $3.36M.
  • Driehaus Capital Management first reported a position in Exagen in Q4 2024 and held it in 3 quarters.
  • Driehaus Capital Management's Exagen position peaked at $3.36M in Q2 2025.
  • 62 funds tracked by Wall St. Rank held Exagen as of Q3 2025.

Based on Driehaus Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.